TCL Archive In Breif: Folkman selected For Karnofsky Lecture; Sporn to give ACS Lecture At ASCO February 2, 1996
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004